Acomo (ACOMO) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
29 Jul, 2026Executive summary
Achieved the second-best H1 results in company history, with sales of €710.7 million and adjusted EBITDA of €61.3 million, despite FX headwinds, commodity volatility, and a challenging geopolitical environment.
Strategic progress included investments, M&A (Citromil, Cublend), ESG initiatives, and the launch of a China office, supporting midterm growth ambitions.
Maintained a strong balance sheet, with a leverage ratio of 2.9x and solvency around 45%.
Interim dividend set at €0.45 per share, unchanged from the prior year.
Robust segment performances, including Spices & Nuts, Edible Seeds, and Tea, with Food Solutions maintaining strong margins.
Financial highlights
H1 2026 sales: €710.7 million, down 3% at constant currency; adjusted EBITDA: €61.3 million, margin 8.6%.
Gross profit: €116.9 million, margin improved to 16.4%; adjusted operating income: €52.1 million.
Net profit: €33.5 million; adjusted EPS: €1.13; basic EPS: €0.94.
Net cash from operations was €56 million, up year-over-year due to lower inventory and improved working capital.
Net debt reduced to €344.4 million; all covenants met.
Outlook and guidance
Expect a more balanced split between H1 and H2 results due to normalized price developments and stable operating conditions.
Working capital expected to decline further in H2, mainly from lower cocoa prices, supporting cash generation.
Committed to 2029 midterm targets and ongoing strategic initiatives, with positive trends in plant-based diets.
Geopolitical risks and super El Niño may impact supply chains and costs.
Latest events from Acomo
- Q1 2025 sales up 16% to €388.8M, driven by Organic Ingredients and Spices & Nuts growth.ACOMO
Q1 2025 TU - Q1 2026 sales were resilient, led by Spices & Nuts growth and a rebound in Edible Seeds.ACOMO
Q1 2026 TU - Record results driven by strong segment growth, with sustainability and normalization ahead.ACOMO
H2 2025 - Q3 sales up 6% to €357.3M, led by Spices, Nuts, and Organic Ingredients; US remains challenging.ACOMO
Q3 2025 TU - Record sales and profit growth in H1 2025, led by Spices & Nuts and Organic Ingredients.ACOMO
H1 2025 - Q3 revenue up 14% year-over-year, led by Spices and Nuts and Organic Ingredients growth.ACOMO
Q3 2024 TU - EBITDA fell 9% as cocoa volatility offset record Spices & Nuts growth; dividend held at €0.40.ACOMO
H1 2024 - Aims for €2B sales and 9% EBITDA margin via growth in plant-based, value-added ingredients.ACOMO
CMD 2025 - Record profit and EBITDA growth, strong H2, and major sustainability gains achieved.ACOMO
H2 2024